Compounds > tuftsin
Page last updated: 2024-09-04

tuftsin and nystatin a1

tuftsin has been researched along with nystatin a1 in 5 studies

Compound Research Comparison

Studies
(tuftsin)		Trials
(tuftsin)		Recent Studies (post-2010)
(tuftsin)		Studies
(nystatin a1)		Trials
(nystatin a1)		Recent Studies (post-2010) (nystatin a1)
5344583,585246504

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haq, W; Khan, MA; Nasti, HT; Owais, M; Saima Dagger, K; Shehbaz, A; Syed, FM1
Ahmad, N; Firoz, A; Khan, MA; Mallick, AI; Mohammad, O; Nasti, TH; Saima, K; Wajahul, H1
Firoz, A; Jabeen, R; Khan, MA; Mohammad, O1
Faisal, SM; Khan, MA; Mohammad, O1
Aljarbou, A; Khan, A; Khan, MA; Owais, M1

Other Studies

5 other study(ies) available for tuftsin and nystatin a1

ArticleYear
Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B.
    Journal of drug targeting, 2003, Volume: 11, Issue:2

    Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antibiotic Prophylaxis; Antifungal Agents; Candida albicans; Candidiasis; Cholesterol; Chromatography, High Pressure Liquid; Female; Liposomes; Mice; Mice, Inbred BALB C; Nystatin; Phosphatidylcholines; Tuftsin

2003
Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
    FEMS immunology and medical microbiology, 2004, Jul-01, Volume: 41, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Synergism; Drug Therapy, Combination; Female; Liposomes; Mice; Mice, Inbred BALB C; Neutropenia; Nystatin; Treatment Outcome; Tuftsin

2004
Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice.
    Journal of drug targeting, 2004, Volume: 12, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Compounding; Drug Resistance, Fungal; Female; Immunologic Factors; Intercalating Agents; Kidney; Leukopenia; Lipopolysaccharides; Liposomes; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nystatin; Staphylococcal Protein A; Tuftsin

2004
Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model.
    Journal of drug targeting, 2006, Volume: 14, Issue:4

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Humans; Immunologic Factors; Liposomes; Male; Mice; Microbial Sensitivity Tests; Nystatin; Treatment Outcome; Tuftsin

2006
Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice.
    FEMS immunology and medical microbiology, 2012, Volume: 66, Issue:1

    Topics: Animals; Antifungal Agents; Brain; Cells, Cultured; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Immunologic Factors; Liposomes; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nystatin; Survival Analysis; Treatment Outcome; Tuftsin

2012